Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access. PRMA Consulting Ltd
Darren McBride shares his experience of digital transformation in pharmaceutical and biotechnology market access, and makes four recommendations for those who are keen to drive change. PRMA Consulting Ltd
Pharmaceutical and biotechnology companies are turning to technology more frequently to solve business issues, and are increasingly using digital technology to optimize market access for their products.Read the article >> https://www.prmaconsulting.com/digital_applications_whitepaper/index.html?utm_source=PMLiVE&utm_medium=HubArticle&utm_campaign=DigitalTransThis new article helps you to:appreciate why digital applications are transforming the value and access functionsunderstand how new technology is informing direction and becoming an essential enabler in realizing visiongain insight into considerations for re-evaluating your technology and your suppliers. PRMA Consulting Ltd
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy. PRMA Consulting Ltd